Patent · US Active

Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine

US8491931B2 · kind B2 · utility

0Cited by

0References

21Claims

0Family size

Assignee

NORGINE BV · NL

Inventors

Norman Barras · Cowbridge, GB
Jeffrey M. Thompson · Minneapolis, US

Key dates

Filing date	Sep 30, 2009
Grant date	Jul 23, 2013
Priority date	—
Expiry date	Jan 29, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

1R,2S-Methoxamine may be used topically for effective treatment of faecal incontinence at low doses without local or systemic side effects, for example, without affecting blood pressure. 1R,2S-Methoxamine may be used to treat other disturbances and disorders of the gastrointestinal, as a pressor agent, as a nasal decongestant and in ophthalmology, at low does and without significant side effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.